1. P3.226 Pre-Exposure Prophylaxis (PrEP) is Estimated to Be a Cost-Effective Addition to Antiretroviral Therapy (ART) For HIV Prevention in a Generalised Epidemic Setting. (13th July 2013) Authors: Ying, R; Celum, C; Baeten, J; Murnane, P; Hong, T; Krows, M; Rooyen, H van; Humphries, H; Hughes, J P; Barnabas, R Journal: Sexually transmitted infections Issue: Volume 89(2013)Supplement 1 Page Start: A219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗